SEC 13F Intelligence

Dekabank Deutsche Girozentrale / PFE

Dekabank Deutsche Girozentrale’s Pfizer Inc Position

Does Dekabank Deutsche Girozentrale own Pfizer Inc (PFE)? Yes7.40M shares worth $211M (+0.35% of its 13F portfolio) as of Q1 2026.

Position Value
$211M
Q1 2026
Shares
7.40M
% of Portfolio
+0.35%
Quarters Held
28
currently held

Position History PFE

Reported value by quarter
Q1 ’19: $313MQ1 ’19Q2 ’19: $354MQ3 ’19: $260MQ4 ’19: $276MQ1 ’20: $217MQ1 ’20Q2 ’20: $192MQ3 ’20: $241MQ1 ’21: $243MQ2 ’21: $241MQ2 ’21Q3 ’21: $250MQ4 ’21: $402MQ1 ’22: $431MQ2 ’22: $425MQ2 ’22Q3 ’22: $362MQ4 ’22: $396MQ1 ’23: $317MQ2 ’23: $303MQ2 ’23Q3 ’23: $250MQ4 ’23: $235MQ1 ’24: $205MQ2 ’24: $205MQ2 ’24Q3 ’24: $215MQ4 ’24: $196MQ1 ’25: $183MQ2 ’25: $180MQ2 ’25Q3 ’25: $176MQ4 ’25: $208MQ1 ’26: $211Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20267.40M$211M+0.35%
Q4 20257.40M$208M+0.36%
Q3 20257.40M$176M+0.30%
Q2 20257.40M$180M+0.32%
Q1 20257.38M$183M+0.36%
Q4 20247.40M$196M+0.36%
Q3 20247.40M$215M+0.40%
Q2 20247.31M$205M+0.37%
Q1 20247.38M$205M+0.38%
Q4 20238.16M$235M+0.48%
Q3 20237.75M$250M+0.58%
Q2 20238.32M$303M+0.68%
Q1 20237.86M$317M+0.80%
Q4 20227.73M$396M+1.05%
Q3 20228.19M$362M+1.07%
Q2 20228.35M$425M+1.24%
Q1 20228.20M$431M+1.05%
Q4 20216.94M$402M+0.98%
Q3 20215.75M$250M+0.70%
Q2 20216.18M$241M+0.70%
Q1 20216.67M$243M+0.81%
Q3 20206.65M$241M+1.07%
Q2 20205.83M$192M+1.21%
Q1 20206.68M$217M+1.66%
Q4 20197.02M$276M+1.69%
Q3 20197.17M$260M+1.61%
Q2 20198.14M$354M+1.78%
Q1 20197.52M$313M+1.86%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dekabank Deutsche Girozentrale’s full portfolio or all institutional holders of PFE.